The Miller Lab The Miller Lab The Miller Lab
  • Our Approach
  • Meet The Team
  • Publications
  • Presentations
  • Posts
  • Software
  • Funding
  • Slides
  • Donate
2026
CME
CSCC
BCC
At this live CME course developed and produced by Plexus Communications, Dr. Miller explores key clinical practice insights for patients with advanced non-melanoma skin cancer.
Author

David M. Miller

Published

May 12, 2026

Live Continuing Medical Education

Advanced Non-Melanoma Skin Cancer in Veterans

Incorporating advances in immune checkpoint inhibitors to optimize outcomes.

CME CSCC BCC Immunotherapy
Presenter David M. Miller, MD, PhD
Date May 12, 2026
Format Live CME course

Event

Gainesville Veterans Affairs Medical Center

Overview

This program explores evidence-based care for patients with advanced non-melanoma skin cancer, with a focus on how recent advances in immune checkpoint inhibition can inform clinical decision-making and improve outcomes.

Program support: This activity was developed and produced by Plexus Communications, the Association of VA Hematology/Oncology, and Medical Education Resources, and was supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

This site represents our opinions only. See our full Disclaimer and Terms of Use Agreement.